Page last updated: 2024-10-26

embelin and ER-Negative PR-Negative HER2-Negative Breast Cancer

embelin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Xu, Y1
Liu, D1
Hu, J1
Ding, P1
Chen, M1
Hussain, AR1
Siraj, AK1
Ahmed, M1
Bu, R1
Pratheeshkumar, P1
Alrashed, AM1
Qadri, Z1
Ajarim, D1
Al-Dayel, F1
Beg, S1
Al-Kuraya, KS1

Other Studies

2 other studies available for embelin and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
    International journal of pharmaceutics, 2020, Jan-05, Volume: 573

    Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Drug Carriers; Female; Humans; Hy

2020
XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
    BMC cancer, 2017, Sep-11, Volume: 17, Issue:1

    Topics: Adult; Aged; Animals; Apoptosis; Benzoquinones; Biomarkers, Tumor; Chromones; Female; Gene Expressio

2017